Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Zug, Switzerland, August 3, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
-
Zug, Switzerland, July 2, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
-
Zug, Switzerland, and Sydney, Australia, June 25, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing injectable therapeutics for inner ear disorders,...
-
Zug, Switzerland, June 17, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
-
Zug, Switzerland, June 2, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
-
Zug, Switzerland, May 28, 2015 - Auris Medical Holding AG (NASDAQ: EARS) today provided an update on the Company's business and announced financial results for the first quarter ended March 31,...
-
Zug, Switzerland, May 22, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
-
Zug, Switzerland, May 20, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
-
Zug, Switzerland, May 18, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
-
Zug, Switzerland, May 15, 2015 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...